ClinVar Miner

Submissions for variant NM_138361.5(LRSAM1):c.2003_2015del (p.Leu668fs) (rs876661208)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000214054 SCV000279792 likely pathogenic not provided 2016-01-22 criteria provided, single submitter clinical testing The c.2003_2015del13 variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.2003_2015del13 variant causes a frameshift starting with codon Leucine 668, changes this amino acid to a Proline residue and creates a premature Stop codon at position 14 of the new reading frame, denoted p.Leu668ProfsX14. This variant is predicted to cause loss of normal protein function through protein truncation as the last 56 amino acids of the LRSAM1 protein are lost and replaced with 13 incorrect amino acids. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.
Invitae RCV000696532 SCV000825096 likely pathogenic Charcot-Marie-Tooth disease type 2P 2018-05-17 criteria provided, single submitter clinical testing This sequence change results in a premature translational stop signal in the LRSAM1 gene (p.Leu668Profs*14). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 58 amino acids of the LRSAM1 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with LRSAM1-related disease. ClinVar contains an entry for this variant (Variation ID: 234769). Other truncations (c.2021_2024del, c.2043_2044dupGG and c.2047-1G>A) that lie downstream of this variant have been reported in individuals affected with autosomal dominant Charcot-Marie-Tooth disease (PMID:29341362, 22781092, 28286897, Invitae). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.